First-Line Therapies in Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

First-Line Therapies in Inflammatory Bowel Disease

Published:2012 Issue:s1 Volume:86 Page:6-10
ISSN:1421-9867
Container-title:Digestion
language:en
Short-container-title:Digestion

Author:

Girardin Marc,Manz Michael,Manser Christine,Biedermann Luc,Wanner Roger,Frei Pascal,Safroneeva Ekaterina,Mottet Christian,Rogler Gerhard,Schoepfer Alain M.

Publisher

S. Karger AG

Subject

Gastroenterology

Reference30 articles.

1. Inflammatory bowel disease pathogenesis

2. Frequency and Risk Factors for Extraintestinal Manifestations in the Swiss Inflammatory Bowel Disease Cohort

3. Budesonide 9 mg Is at Least as Effective as Mesalamine 4.5 g in Patients With Mildly to Moderately Active Crohn's Disease

4. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Relationship Between Endoscopic Findings and Laboratory Results in Inflammatory Bowel Diseases;Hitit Medical Journal;2024-06-30

2. The NF-κB signaling system in the immunopathogenesis of inflammatory bowel disease;Science Signaling;2024-01-09

3. Cell membrane nanomaterials composed of phospholipids and glycoproteins for drug delivery in inflammatory bowel disease: A review;International Journal of Biological Macromolecules;2023-09

4. Medical Therapy for Crohn’s Disease;The ASCRS Textbook of Colon and Rectal Surgery;2021-11-21

5. Effectiveness and Nephrotoxicity of Long-Term Tacrolimus Administration in Patients with Ulcerative Colitis;Journal of Clinical Medicine;2020-06-07